In agreement, tissues from breast cancer patients of triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, showed CD44+, CD24–, and high ALDH1 phenotype compared to the nonTNBC tissues (Honeth et al., 2008; Li et al., 2013; Ma et al., 2014). This evidence concerns the gene CD44 and breast cancer.